Some psychedelic drugs, once considered fringe, are getting a step closer to possibly being approved for use as mental health treatments in the United States. The US Food and Drug Administration on ...

A PSYCHEDELICS ‘BREAKTHROUGH’? The list of products receiving FDA Commissioner Marty Makary’s priority review vouchers will grow this week to include three psychedelic drugs after a White House ...

The FDA's fast-track nicotine pouch approval plan is running into resistance because regulators and outside critics are still uneasy about the science and the possibility of creating new nicotine ...

Fast Track Debt Relief is a debt relief company that primarily focuses on helping consumers resolve unsecured debt through settlement programs. The company may also connect clients with lending ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Delta announced that it was no longer going to allow members of ...

David Ellison’s Paramount Skydance has claimed it has “confidence in the speed and certainty of its regulatory pathway” in closing the acquisition of Warner Bros. Discovery in a $111 billion deal. But ...

Meta is offering guaranteed monthly payments and increased reach on Facebook for creators to join. The Creator Fast Track will pay $1,000 a month to those with at least 100,000 followers on Instagram, ...

Please provide your email address to receive an email when new articles are posted on . Nipocalimab is a potentially steroid sparing, immunoselective treatment designed to block FcRn and target IgG ...

The Dolphins have signed veteran safety Lonnie Johnson Jr. The former second-round pick of the Houston Texans has enjoyed a seven-year NFL career. A college cornerback converted to safety, Johnson Jr.

The Dolphins made their first splash of the free agency period by signing quarterback Malik Willis. A third-round pick by Tennessee in 2022, Willis was traded to Green Bay ahead of the 2024 season ...

The U.S. Food and Drug Administration (FDA) has granted Johnson & Johnson’s, nipocalimab, Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). This ...